CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kensler, T. W.
Right arrow Articles by Talalay, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kensler, T. W.
Right arrow Articles by Talalay, P.
Related Collections
Right arrow Clinical Intervention
Right arrow Clinical Intervention: Biomarkers
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2605-2613, November 2005
© 2005 American Association for Cancer Research

Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China

Thomas W. Kensler1,3, Jian-Guo Chen4, Patricia A. Egner1, Jed W. Fahey3, Lisa P. Jacobson2, Katherine K. Stephenson3, Lingxiang Ye3, Jamie L. Coady1, Jin-Bing Wang4, Yan Wu4, Yan Sun4, Qi-Nan Zhang4, Bao-Chu Zhang4, Yuan-Rong Zhu4, Geng-Sun Qian5, Stephen G. Carmella6, Stephen S. Hecht6, Lorie Benning2, Stephen J. Gange2, John D. Groopman1 and Paul Talalay3

Departments of 1 Environmental Health Sciences and 2 Epidemiology, Bloomberg School of Public Health; 3 Department of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland; 4 Qidong Liver Cancer Institute, Qidong, People's Republic of China; 5 Cancer Institute of Shanghai, Jiao Tong University, Shanghai, People's Republic of China; and 6 University of Minnesota Cancer Center, Minneapolis, Minnesota

Requests for reprints: Thomas W. Kensler, Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Room E7541, 615 North Wolfe Street, Baltimore, MD 21205. Phone: 410-955-4712; Fax: 410-955-0116. E-mail: tkensler{at}jhsph.edu

Residents of Qidong, People's Republic of China, are at high risk for development of hepatocellular carcinoma, in part due to consumption of aflatoxin-contaminated foods, and are exposed to high levels of phenanthrene, a sentinel of hydrocarbon air toxics. Cruciferous vegetables, such as broccoli, contain anticarcinogens. Glucoraphanin, the principal glucosinolate in broccoli sprouts, can be hydrolyzed by gut microflora to sulforaphane, a potent inducer of carcinogen detoxication enzymes. In a randomized, placebo-controlled chemoprevention trial, we tested whether drinking hot water infusions of 3-day-old broccoli sprouts, containing defined concentrations of glucosinolates, could alter the disposition of aflatoxin and phenanthrene. Two hundred healthy adults drank infusions containing either 400 or <3 µmol glucoraphanin nightly for 2 weeks. Adherence to the study protocol was outstanding; no problems with safety or tolerance were noted. Urinary levels of aflatoxin-N7-guanine were not different between the two intervention arms (P = 0.68). However, measurement of urinary levels of dithiocarbamates (sulforaphane metabolites) indicated striking interindividual differences in bioavailability. An inverse association was observed for excretion of dithiocarbamates and aflatoxin-DNA adducts (P = 0.002; R = 0.31) in individuals receiving broccoli sprout glucosinolates. Moreover, trans, anti-phenanthrene tetraol, a metabolite of the combustion product phenanthrene, was detected in urine of all participants and showed a robust inverse association with dithiocarbamate levels (P = 0.0001; R = 0.39), although again no overall difference between intervention arms was observed (P = 0.29). Understanding factors influencing glucosinolate hydrolysis and bioavailability will be required for optimal use of broccoli sprouts in human interventions.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
X.-J. Wang, Z. Sun, N. F. Villeneuve, S. Zhang, F. Zhao, Y. Li, W. Chen, X. Yi, W. Zheng, G. T. Wondrak, et al.
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Carcinogenesis, June 1, 2008; 29(6): 1235 - 1243.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. S. Cornblatt, L. Ye, A. T. Dinkova-Kostova, M. Erb, J. W. Fahey, N. K. Singh, M.-S. A. Chen, T. Stierer, E. Garrett-Mayer, P. Argani, et al.
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
Carcinogenesis, July 1, 2007; 28(7): 1485 - 1490.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. V. Gasper, M. Traka, J. R. Bacon, J. A. Smith, M. A. Taylor, C. J. Hawkey, D. A. Barrett, and R. F. Mithen
Consuming Broccoli Does Not Induce Genes Associated with Xenobiotic Metabolism and Cell Cycle Control in Human Gastric Mucosa
J. Nutr., July 1, 2007; 137(7): 1718 - 1724.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. T. Dinkova-Kostova, J. W. Fahey, K. L. Wade, S. N. Jenkins, T. A. Shapiro, E. J. Fuchs, M. L. Kerns, and P. Talalay
Induction of the Phase 2 Response in Mouse and Human Skin by Sulforaphane-containing Broccoli Sprout Extracts
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 847 - 851.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Pledgie-Tracy, M. D. Sobolewski, and N. E. Davidson
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines
Mol. Cancer Ther., March 1, 2007; 6(3): 1013 - 1021.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.